Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Accured Expenses: 2023-2024

Historic Change in Accured Expenses for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $1.5 million.

  • Upstream Bio's Change in Accured Expenses fell 285.71% to -$481,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 644.44%. This contributed to the annual value of $1.5 million for FY2024, which is 258.29% up from last year.
  • Upstream Bio's Change in Accured Expenses amounted to $1.5 million in FY2024, which was up 258.29% from $422,000 recorded in FY2023.
  • In the past 5 years, Upstream Bio's Change in Accured Expenses registered a high of $1.5 million during FY2024, and its lowest value of $422,000 during FY2023.
  • Moreover, its 2-year median value for Change in Accured Expenses was $967,000 (2023), whereas its average is $967,000.
  • Data for Upstream Bio's Change in Accured Expenses shows a peak YoY surged of 258.29% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Change in Accured Expenses (Yearly) stood at $422,000 in 2023, then spiked by 258.29% to $1.5 million in 2024.